Results 21 to 30 of about 5,338,748 (296)

Targeted radionuclide therapy [PDF]

open access: yesMedical Physics, 2008
Targeted radionuclide therapy (TRT) seeks molecular and functional targets within patient tumor sites. A number of agents have been constructed and labeled with beta, alpha, and Auger emitters. Radionuclide carriers spanning a broad range of sizes; e.g., antibodies, liposomes, and constructs such as nanoparticles have been used in these studies. Uptake,
Lawrence E, Williams   +2 more
openaire   +2 more sources

Targeted therapy in lymphoma [PDF]

open access: yesJournal of Hematology & Oncology, 2010
AbstractDiscovery of new treatments for lymphoma that prolong survival and are less toxic than currently available agents represents an urgent unmet need. We now have a better understanding of the molecular pathogenesis of lymphoma, such as aberrant signal transduction pathways, which have led to the discovery and development of targeted therapeutics ...
Cavalli Franco   +3 more
openaire   +3 more sources

From ‘Targeted Therapy’ to Targeted Therapy [PDF]

open access: yesAnticancer Research, 2019
In early 2000, the term 'targeted therapy' became popular and was used to indicate all types of tyrosine kinase inhibitors (TKI). However, the term targeted therapy had been used much earlier. Targeting tumor metabolism was already considered as targeted therapy, with methotrexate and 5-fluorouracil as the most successful examples.
openaire   +2 more sources

Development of a quantitative methylation-specific droplet digital PCR assay for detecting Dickkopf-related protein 3

open access: yesBMC Research Notes, 2022
Objective The detection and monitoring of DNA methylation status in circulating tumor cell DNA (ctDNA) provides critical insights into cancer diagnosis and progression.
Kenji Araki, Ai Kurosawa, Hiromi Kumon
doaj   +1 more source

Development of a human immuno-oncology therapeutic agent targeting HER2: targeted delivery of granzyme B

open access: yesJournal of Experimental & Clinical Cancer Research, 2019
Background Immunotherapeutic approaches designed to augment T and B cell mediated killing of tumor cells has met with clinical success in recent years suggesting tremendous potential for treatment in a broad spectrum of tumor types.
Lawrence H. Cheung   +6 more
doaj   +1 more source

OX40 and 4-1BB delineate distinct immune profiles in sarcoma

open access: yesOncoImmunology, 2022
Systemic relapse after radiotherapy and surgery is the major cause of disease-related mortality in sarcoma patients. Combining radiotherapy and immunotherapy is under investigation as a means to improve response rates.
MJ Melake   +16 more
doaj   +1 more source

Application of the Linear-Quadratic model to targeted radionuclide therapy [PDF]

open access: yes, 2011
PhDThe principal aim of this work was to test the hypothesis that the Linear-Quadratic (LQ) model of cell survival, developed for external beam radiotherapy (EBRT), could be extended to targeted radionuclide therapy (TRT) in order to predict dose ...
Murray, Iain
core   +4 more sources

Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning

open access: yesFrontiers in Oncology, 2020
ObjectiveTo establish a classifier for accurately predicting the overall survival of gallbladder cancer (GBC) patients by analyzing pre-treatment CT images using machine learning technology.MethodsThis retrospective study included 141 patients with ...
Zefan Liu   +7 more
doaj   +1 more source

Autophagic sequestration of SQSTM1 disrupts the aggresome formation of ubiquitinated proteins during proteasome inhibition

open access: yesCell Death and Disease, 2022
Aggresome formation is a protective cellular response to counteract proteasome dysfunction by sequestering misfolded proteins and reducing proteotoxic stress.
Chenliang Zhang   +5 more
doaj   +1 more source

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients

open access: yesCancer Cell International, 2021
Background Tumor metastasis is one of the leading reasons of the dismal prognosis of hepatocellular carcinoma (HCC). Epithelial-mesenchymal transition (EMT) is closely associated with tumor metastasis including HCC.
Gongmin Zhu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy